Key words: Gemcitabine
Gemcitabine is a kind of pharmaceutical intermediates, 95058-84-1, purity of 99.33% gemcitabine spot is currently on the market more common products. It is a broad-spectrum anticancer drug often used to treat malignant tumors such as pancreatic cancer, lung cancer, and breast cancer. About its function, we have done some sorting and summary.
Gemcitabine is a common component of drug intermediates, and we often use gemcitabine in pharmaceutical products. It’s an injectable drug, often given intravenously or as an intravenous drip. In the pharmaceutical process, gemcitabine, pharmaceutical manufacturers for the application of this ingredient mainly in the following aspects:
1. Pancreatic cancer treatment: Gemcitabine is often used in the treatment of pancreatic cancer, which can relieve symptoms and prolong the survival time of patients.
Lung Cancer Treatment:
2, lung cancer treatment can slow the progression of the disease and improve the quality of life of patients.
3. Breast cancer treatment: It can slow down the progression of the disease and prolong the survival time of patients.
4, other malignant tumor treatment: gemcitabine can also be used for the treatment of other malignant tumors, such as ovarian cancer, stomach cancer, rectal cancer and so on. Action mechanism
Application of gemcitabine to the synthesis of:
1, inhibit DNA synthesis, thereby preventing the proliferation and division of cancer cells, so that cancer cells die.
2, induce apoptosis: gemcitabine can induce apoptosis of cancer cells, thereby promoting cancer cell death.
The mechanism of action of gemcitabine is multifaceted, and it can inhibit the growth and division of cancer cells through multiple ways, so as to achieve the effect of cancer treatment.
In summary, gemcitabine is a widely used anticancer drug that is often used to treat a variety of malignancies.
About Wisdom Drugs
Wisdom Drugs Co .,Ltd was founded in Sep. 2011 whose headquarter located in Changzhou Creative Industry Park, having a branch in India. The company’s R&D center is engaged in not only the process development of APIs, intermediates, poly-peptide compounds and heterocyclic compounds,but also the optimization and production. We are devoted to the synthesis customization and the technology transfer, enabling compounds to be scaled from laboratory to commercial to meet the requirements of different customers.
